In honor Frederick G. Banting’s birth 125 years ago, we present a review of developments in insulin for the year 2016.
T1DM, Pregnancy, and Continuous Glucose Monitoring: Good News
A new open-label randomized controlled trial finds use of CGM in T1DM pregnancies may improve neonatal outcomes.
Impact of Ethnicity, Gender on Skin Autoflourescence and Risk for CV, DM
A new study evaluates the impact of ethnicity on skin autoflourescence used to measure accumulation of atherogenic glycated proteins.
The Revised Cholesterol Guidelines
What about those patients who fall into the "gray zone"?
Low-carbohydrate Diet Controls Glucose Levels in Type 2 Diabetes
The early impact of carbohydrate restriction was clinically significant but not sustained, according to authors of a new meta-analysis.
Early Respiratory Infections and Risk for Type 1 Diabetes: The TEDDY Study
Timing appears to be nearly everything when it comes to the impact of respiratory infection on autoantibody seroconversion in infants at risk for tpye 1 diabetes.
When to Walk Away From an Insurance Company
You can attempt to renegotiate. Sometimes it works . . . but sometimes it doesn’t.
Type 2 Diabetes Patients Show No Increased CV Risk with Once-Weekly Exenatide
The extended-release GLP-1 agonist was added to usual care in T2DM patients with and without previous cardiac disease.
Interesting Endo: AFib, Bone Health, and Obesity
At-a-Glance: Studies you may find of interest look at AFib in T1DM, new fracture risk data, obesity outcomes, and more.
Lifestyle Intervention Reduces Need for Diabetes Medications
In a new study, an intensive lifestyle intervention did not markedly decrease A1c but had significant impact on need for medication.
The Artificial Sweetener Paradox: Weight Gain and Metabolic Dysfunction?
A new meta-analysis finds that routine intake of artificial sweeteners is linked to the opposite of the intended effect.